Journal article

Selective COX-2 inhibitors: where do we go from here?

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Baigent, C., & Patrono, C. (2008). Selective COX-2 inhibitors: where do we go from here? Lancet, 372(9651), 1712–1713.

MLA Style

Baigent, C, and C Patrono. “Selective COX-2 Inhibitors: Where Do We Go from Here?” Lancet, vol. 372, no. 9651, 2008, pp. 1712–13.

Chicago Style

Baigent, C, and C Patrono. 2008. “Selective COX-2 Inhibitors: Where Do We Go from Here?” Lancet 372 (9651): 1712–13.
Print

Access Document

Publisher copy:: 10.1016/S0140-6736(08)61491-9

Authors

+ Baigent, C More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Nuffield Department of Population Health
Sub department:: Clinical Trial Service Unit
Role:: Author

+ Patrono, C More by this author

Role:: Author

Journal:: Lancet More from this journal
Volume:: 372
Issue:: 9651
Pages:: 1712-1713
Place of publication:: England
Publication date:: 2008-11-15
DOI:: 10.1016/S0140-6736(08)61491-9
EISSN:: 1474-547X
ISSN:: 0140-6736

Language:: English
Keywords:: Humans

Randomized Controlled Trials as Topic

Lactones

Sulfones

Cyclooxygenase 2 Inhibitors

Thrombosis
Pubs id:: pubs:49482
UUID:: uuid:13b55d55-b44f-4521-8753-499e8604093c
Local pid:: pubs:49482
Source identifiers:: 49482
Deposit date:: 2013-02-20
ARK identifier:: ark:/29072/ora_13b55d55b44f45218753499e8604093c

Terms of use

Copyright date:: 2008

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP